These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 33313060)
21. Serum levels of soluble secreted α-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis. Shimamura Y; Hamada K; Inoue K; Ogata K; Ishihara M; Kagawa T; Inoue M; Fujimoto S; Ikebe M; Yuasa K; Yamanaka S; Sugiura T; Terada Y Clin Exp Nephrol; 2012 Oct; 16(5):722-9. PubMed ID: 22457086 [TBL] [Abstract][Full Text] [Related]
22. Association between FGF23, α-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages. Tanaka S; Fujita S; Kizawa S; Morita H; Ishizaka N PLoS One; 2016; 11(7):e0156860. PubMed ID: 27400031 [TBL] [Abstract][Full Text] [Related]
23. New insights into the FGF23-Klotho axis. Olauson H; Vervloet MG; Cozzolino M; Massy ZA; Ureña Torres P; Larsson TE Semin Nephrol; 2014 Nov; 34(6):586-97. PubMed ID: 25498378 [TBL] [Abstract][Full Text] [Related]
24. The controversy of klotho as a potential biomarker in chronic kidney disease. Yu LX; Li SS; Sha MY; Kong JW; Ye JM; Liu QF Front Pharmacol; 2022; 13():931746. PubMed ID: 36210812 [TBL] [Abstract][Full Text] [Related]
25. Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Lim K; Lu TS; Molostvov G; Lee C; Lam FT; Zehnder D; Hsiao LL Circulation; 2012 May; 125(18):2243-55. PubMed ID: 22492635 [TBL] [Abstract][Full Text] [Related]
26. [Decreased Serum Levels of Klotho Protein in Chronic Kidney Disease Patients: Clinical Imortance]. Milovanova LY; Mukhin NA; Kozlovskaya LV; Milovanov YS; Kiyakbaev GG; Rogova IV; Lebedeva MV; Androsova TV; Milovanova SY; Gil AY; Taranova MV Vestn Ross Akad Med Nauk; 2016; 71(4):288-96. PubMed ID: 29297646 [TBL] [Abstract][Full Text] [Related]
27. Implications of Klotho Protein for Managing Kidney Disease - an Emerging Role in Therapeutics and Molecular Medicine. Ray SK; Masarkar N; Mukherjee S Curr Mol Med; 2021; 21(6):484-494. PubMed ID: 33222666 [TBL] [Abstract][Full Text] [Related]
28. [Significance of the morphogenetic proteins FGF-23 and Klotho as predictors of prognosis of chronic kidney disease]. Milovanova LIu; Milovanov IuS; Kozlovskaia LV; Mukhin NA Ter Arkh; 2014; 86(4):36-44. PubMed ID: 24864466 [TBL] [Abstract][Full Text] [Related]
29. Circulating α-klotho levels in CKD and relationship to progression. Kim HR; Nam BY; Kim DW; Kang MW; Han JH; Lee MJ; Shin DH; Doh FM; Koo HM; Ko KI; Kim CH; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260 [TBL] [Abstract][Full Text] [Related]
30. [New markers of cardio-renal links in chronic kidney disease]. Milovanova LIu; Milovanov IuS; Kozlovskaia LV; Mukhin NA Ter Arkh; 2013; 85(6):17-24. PubMed ID: 23866594 [TBL] [Abstract][Full Text] [Related]
31. A Decreased Level of Soluble Klotho Can Predict Cardiovascular Death in No or Mild Abdominal Aortic Calcification Hemodialysis Patients. Cai H; Zhu X; Lu J; Zhu M; Liu S; Zhan Y; Ni Z; Gu L; Zhang W; Mou S Front Med (Lausanne); 2021; 8():672000. PubMed ID: 34079811 [No Abstract] [Full Text] [Related]
32. Calcification of coronary arteries and aortic valve and circulating a-klotho levels in patients with chronic kidney disease. Savvoulidis P; Kalogeropoulos AP; Raptis V; Rafailidis V; Georgianos PI; Balaskas EV; Kouskouras K; Karvounis H; Hadjimiltiades S J Thorac Dis; 2020 Mar; 12(3):431-437. PubMed ID: 32274109 [TBL] [Abstract][Full Text] [Related]
33. Klotho connects intermedin1-53 to suppression of vascular calcification in chronic kidney disease. Hu MC Kidney Int; 2016 Mar; 89(3):534-7. PubMed ID: 26880448 [TBL] [Abstract][Full Text] [Related]
34. Klotho, the Holy Grail of the kidney: from salt sensitivity to chronic kidney disease. Kalaitzidis RG; Duni A; Siamopoulos KC Int Urol Nephrol; 2016 Oct; 48(10):1657-66. PubMed ID: 27215557 [TBL] [Abstract][Full Text] [Related]
35. Intermedin1-53 attenuates vascular calcification in rats with chronic kidney disease by upregulation of α-Klotho. Chang JR; Guo J; Wang Y; Hou YL; Lu WW; Zhang JS; Yu YR; Xu MJ; Liu XY; Wang XJ; Guan YF; Zhu Y; Du J; Tang CS; Qi YF Kidney Int; 2016 Mar; 89(3):586-600. PubMed ID: 26880455 [TBL] [Abstract][Full Text] [Related]
36. Coronary artery calcification and cardiovascular disease in children with chronic kidney disease. Paoli S; Mitsnefes MM Curr Opin Pediatr; 2014 Apr; 26(2):193-7. PubMed ID: 24632542 [TBL] [Abstract][Full Text] [Related]
37. Implications of Klotho in vascular health and disease. Martín-Núñez E; Donate-Correa J; Muros-de-Fuentes M; Mora-Fernández C; Navarro-González JF World J Cardiol; 2014 Dec; 6(12):1262-9. PubMed ID: 25548616 [TBL] [Abstract][Full Text] [Related]
38. Renal Klotho safeguards platelet lifespan in advanced chronic kidney disease through restraining Bcl-xL ubiquitination and degradation. Lan Q; Du C; Xiong J; Wu Y; Liao W; Liu C; Chen J; Ran L; Wang Y; Wang Y; Wang J; Zhao J; Yang K J Thromb Haemost; 2022 Dec; 20(12):2972-2987. PubMed ID: 36087344 [TBL] [Abstract][Full Text] [Related]
39. Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis. Levin A Semin Dial; 2003; 16(2):101-5. PubMed ID: 12641872 [TBL] [Abstract][Full Text] [Related]